Consultant
CurrentNeurofix was a company that developed a drug to treat ADHD and other indications. The company was sold to a publicly traded entity in September 2015. Supported management in various areas including negotiations with the non-profit partner, sourcing potential suitors and legal structure. Provided analysis on economic value of potential revenue streams to a public company in anticipation of a stock/cash transaction at exit. Currently providing similar services to clinical stage Arctic Therapeutics.